IL6 and COVID-19: In addition, the results show an increase in the number of tests for biomarkers used for the evaluation and monitoring of COVID-19 inpatients (IL-6, D-dimer, troponin, arterial blood gases and ferritin), which even increased in 2021 with respect to 2020 for IL-6 and ferritin.